Similarly, TIGAR, a downstream effector of p53, regulates glycolysis and antioxidant defense; its upregulation promotes cell survival, while TIGAR knockdown has been shown to induce apoptosis and autophagy in HCC cells, suggesting its role in metabolic adaptation and therapy resistance [25]. This evidence concerns the gene TIGAR and hepatocellular carcinoma.